Form 4 for TECH Bio-Techne
Accepted 2022-08-12 00:00:00 ET · period of report 2022-08-10 · accession 0001437749-22-020338 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-08-12 | 2022-08-10+ | TECH | HIGGINS JOHN L | Dir | S - Sale+OE | $378.80 | -2,504 | 7,106 | -26% | -$948.5K |
| D | 2022-08-12 | 2022-08-10 | TECH | HIGGINS JOHN L | Dir | M - OptEx | $66.90 | +3,400 | 8,006 | +74% | +$227.5K |
| D | 2022-08-12 | 2022-08-10 | TECH | HIGGINS JOHN L | Dir | M - OptEx | $0.00 | -3,400 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-10 | S | D | 100 | $374.90 | 7,006 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from 374.8950 to 374.9000, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2022-08-10 | S | D | 992 | $380.15 | 6,014 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from 380.0000 to 380.4400, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2022-08-11 | S | D | 504 | $385.47 | 5,510 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from 385.2900 to 385.8900, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 4 | Common | Common Stock | 2022-08-11 | S | D | 8 | $380.71 | 5,502 | D | — | — | |
| 5 | Common | Common Stock | 2022-08-10 | M | A | 3,400 | $66.90 | 8,006 | D | — | — | |
| 6 | Common | Common Stock | 2022-08-10 | S | D | 900 | $373.99 | 7,106 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from 373.8600 to 374.3300, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 7 | Derivative | Stock Option (right to buy) | 2022-08-10 | M | D | 3,400 | $0.00 | 0 | D | $66.90 · 2012-10-25 to 2022-10-24 | 3,400 Common Stock |